<SEC-DOCUMENT>0001213900-26-086393-index.html : 20260807
<SEC-HEADER>0001213900-26-086393.hdr.sgml : 20260807
<ACCEPTANCE-DATETIME>20260807070322
ACCESSION NUMBER:		0001213900-26-086393
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20260807
FILED AS OF DATE:		20260807
DATE AS OF CHANGE:		20260807

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PURPLE BIOTECH LTD.
		CENTRAL INDEX KEY:			0001614744
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			L3
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37643
		FILM NUMBER:		261251378

	BUSINESS ADDRESS:	
		STREET 1:		4 OPPENHEIMER STREET
		STREET 2:		SCIENCE PARK
		CITY:			REHOVOT
		STATE:			L3
		ZIP:			7670104
		BUSINESS PHONE:		97239333121

	MAIL ADDRESS:	
		STREET 1:		4 OPPENHEIMER STREET
		STREET 2:		SCIENCE PARK
		CITY:			REHOVOT
		STATE:			L3
		ZIP:			7670104

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Kitov Pharma Ltd.
		DATE OF NAME CHANGE:	20180125

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Kitov Pharmaceuticals Holdings Ltd.
		DATE OF NAME CHANGE:	20140724
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>ea0300940-6k_purple.htm
<DESCRIPTION>REPORT OF FOREIGN PRIVATE ISSUER
<TEXT>
Document 1 - file: ea0300940-6k_purple.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ea030094001ex99-1.htm
<DESCRIPTION>PURPLE BIOTECH REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS
<TEXT>
Document 2 - file: ea030094001ex99-1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>ea030094001ex99-2.htm
<DESCRIPTION>PURPLE BIOTECH LTD. CONDENSED CONSOLIDATED UNAUDITED INTERIM FINANCIAL STATEMENTS AS OF JUNE 30, 2026
<TEXT>
Document 3 - file: ea030094001ex99-2.htm

</DOCUMENT>
</SEC-DOCUMENT>